BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 28353057)

  • 1. Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy.
    Tan J; Paquette V; Levine M; Ensom MHH
    Clin Pharmacokinet; 2017 Nov; 56(11):1267-1285. PubMed ID: 28353057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?
    Johannessen SI; Tomson T
    Clin Pharmacokinet; 2006; 45(11):1061-75. PubMed ID: 17048972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication.
    Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI
    Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs.
    Contin M; Albani F; Riva R; Baruzzi A
    Ther Drug Monit; 2004 Aug; 26(4):375-9. PubMed ID: 15257066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levetiracetam use in pregnancy.
    Longo B; Forinash AB; Murphy JA
    Ann Pharmacother; 2009 Oct; 43(10):1692-5. PubMed ID: 19690219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levetiracetam: treatment in epilepsy.
    Ben-Menachem E
    Expert Opin Pharmacother; 2003 Nov; 4(11):2079-88. PubMed ID: 14596661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam.
    Kaminski RM; Matagne A; Patsalos PN; Klitgaard H
    Epilepsia; 2009 Mar; 50(3):387-97. PubMed ID: 18627416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levetiracetam: a different approach to the pharmacotherapy of epilepsy.
    Welty TE; Gidal BE; Ficker DM; Privitera MD
    Ann Pharmacother; 2002 Feb; 36(2):296-304. PubMed ID: 11847952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of levetiracetam as an anti-epileptic drug.
    Jain KK
    Expert Opin Investig Drugs; 2000 Jul; 9(7):1611-24. PubMed ID: 11060765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetic characteristics of levetiracetam.
    Patsalos PN
    Methods Find Exp Clin Pharmacol; 2003 Mar; 25(2):123-9. PubMed ID: 12731458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary efficacy of levetiracetam in children.
    Glauser TA; Dulac O
    Epileptic Disord; 2003 May; 5 Suppl 1():S45-50. PubMed ID: 12915341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characteristics and indications of levetiracetam].
    Herranz JL; Argumosa A
    Rev Neurol; 2002 Sep; 35 Suppl 1():S110-6. PubMed ID: 12373663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levetiracetam: a novel antiepileptic drug.
    Hovinga CA
    Pharmacotherapy; 2001 Nov; 21(11):1375-88. PubMed ID: 11714211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy.
    Lancelin F; Franchon E; Kraoul L; Garciau I; Brovedani S; Tabaouti K; Landré E; Chassoux F; Paubel P; Piketty ML
    Ther Drug Monit; 2007 Oct; 29(5):576-83. PubMed ID: 17898647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
    Otoul C; De Smedt H; Stockis A
    Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic profile of levetiracetam: toward ideal characteristics.
    Patsalos PN
    Pharmacol Ther; 2000 Feb; 85(2):77-85. PubMed ID: 10722121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Drug Monitoring of Levetiracetam in Different Trimesters of Pregnant Women with Epilepsy in a Tertiary Care Center: A Prospective Study.
    Kumaravel J; Sarma P; Suri V; Singh P; Prakash A; Medhi B
    Neurol India; 2024 Mar; 72(2):358-363. PubMed ID: 38691482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of levetiracetam in infants and young children with epilepsy.
    Glauser TA; Mitchell WG; Weinstock A; Bebin M; Chen D; Coupez R; Stockis A; Lu ZS
    Epilepsia; 2007 Jun; 48(6):1117-22. PubMed ID: 17442002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Levetiracetam].
    Salas-Puig J; Calleja S
    Neurologia; 2001 Nov; 16(9):427-32. PubMed ID: 11742623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newer therapies in the drug treatment of epilepsy.
    McAuley JW; Biederman TS; Smith JC; Moore JL
    Ann Pharmacother; 2002 Jan; 36(1):119-29. PubMed ID: 11816240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.